Discussing Rheumatology: July 2023
The IMID Forum19 Jul 2023

Discussing Rheumatology: July 2023

Join Prof Iain McInnes as he reviews two interesting papers. Our first paper today by Roy Fleischmann and his colleagues compares the incidence of serious adverse events in RA patients with a higher risk of cardiovascular events and the overall RA population in a post-hoc study. They also compared the incidence rate of adverse events for upadacitinib, adalimumab and methotrexate, or methotrexate monotherapy. In our second paper, Mohammed Khan and colleagues compared tofacitinib against methotrexate as first-line therapies against RA, with a focus on treatment remission.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(417)

Discussing RA: Biologic effectiveness and treatment persistence in RA

Discussing RA: Biologic effectiveness and treatment persistence in RA

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Finckh et al. and Charles‑Schoeman et a...

27 Aug 8min

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s conversation explores rec...

20 Aug 24min

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Join Professor Peter Nash from the Griffith University in Brisbane; Professor Axel Finckh, from the Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland; and Bente Glintborg, an ...

13 Aug 26min

Discussing RA: Advanced therapy outcomes in RA

Discussing RA: Advanced therapy outcomes in RA

Join Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key findings from studies b...

30 Jul 27min

Author Interview: Professor Laura Coates, July 2026

Author Interview: Professor Laura Coates, July 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Scie...

22 Jul 26min

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ix...

16 Jul 23min

Author Interview: Dr Murat Torgutalp, June 2026

Author Interview: Dr Murat Torgutalp, June 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Murat Torgutalp, from the Charité – Universitätsmedizin in Berlin, as they discuss his recent paper ‘Frequency and characteri...

9 Jul 29min

Discussing RA: Infectious complications of RA treatments

Discussing RA: Infectious complications of RA treatments

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review two recent studies by Etani et al. and George et ...

25 Jun 9min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
rss-orjasater
foreldreradet
jakt-og-fiskepodden
rss-strid-de-norske-borgerkrigene
rss-kunsten-a-leve
sinnsyn
hverdagspsyken
rss-var-forste-kaffe
rss-impressions-2
gravid-uke-for-uke
mikkels-paskenotter
fryktlos
tomprat-med-gunnar-tjomlid
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
hr-podden-2
rss-renters-rente